The Psychiatric Nurses Association has called for a review of the HSE’s contracts with Israeli pharma giant Teva Pharmaceuticals amid a growing campaign against the company. The organisation wrote to health minister Jennifer Carroll MacNeill to urge a review of the HSE’s commercial relations with Teva in response to the “relentless onslaught on the Palestinian people”. “The war on Gaza was raised in motions at our Annual Delegate Conference earlier this year specifically in relation to the purchasing by the HSE of Israeli sourced medications such as the TEVA brand,” the letter, signed by PNA general secretary, Peter Hughes, said.…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .